Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

MITOLINE®-Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets Neve Yarak, Israel, June 22, ...
Science Daily

Researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures

Researchers developed a fully open-source biomolecular structure prediction model that achieves state-of-the-art performance, at the level of AlpahFold3, in an effort to democratize biomedical ...
EurekAlert!

MIT researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures

Gabriele Corso (left) and Jeremy Wohlwend (at podium) presented their new model at a Dec. 5 event at MIT’s Stata Center, where they said their ultimate goal is to foster global collaboration, ...

Nexentis Technologies Inc.: Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule ...

MITOLINE- -Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets Neve Yarak, Israel, June 22 ...